Media News

New digital health technology and integrated solutions business that will deploy a range of health technology assets, proprietary data analytics and extensive health expertise. Accelerates AIA's Health & Wellness strategy and positions the Group to capture significant new opportunities from the rapidly growing health market in Asia. Opens up...

TOKYO, Feb. 15, 2022  /PRNewswire/ -- HPG Co., Ltd. (Chuo-ku, Tokyo) has successfully developed a water-soluble formulation technology of highly concentrated catechin EGCg (Epigallocatechin gallate) with excellent storage stability and initiated procedures for a patent application for the technology to stabilize the product at a high concentration in aqueous solution. Green tea catechin EGCg has inactivating effects against...

SHANGHAI, Feb. 15, 2022 /PRNewswire/ -- AffaMed Therapeutics ("AffaMed"), a global clinical stage biotechnology company dedicated to developing and commercializing transformative pharmaceutical, digital and surgical products, today announced that the United States Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for the clinical development of AM712 (ASKG712), a novel proprietary bispecific biologic molecule blocking...

TAIZHOU, China, Feb. 15, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. (Recbio), a China-based company focused on the development of innovative vaccines for major diseases, announced preclinical data of its subsidiary Wuhan Recogen Biotechnology Co., Ltd. (Recogen) on lyophilized mRNA vaccine. The lyophilized mRNA-LNP nanoparticle vaccine is delivered by an LNP delivery system and achieved stability at 4℃ and 25℃ based...

HONG KONG, Feb. 15, 2022 /PRNewswire/ -- IMI - Integrated Medicine Institute, Asia's largest natural health clinic, is pleased to announce the availability of G-NiiB Immunity Pro and G-NiiB Immunity Plus probiotic formulas designed to tackle gut bacterial imbalances (dysbiosis) - a widespread health issue linked to poor antibody response to COVID vaccinations, severity of COVID-19 symptoms, and development...

- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest generation Radixact® System SUNNYVALE, Calif., Feb. 15, 2022...

Nuvaxovid™ is the first protein-based COVID-19 vaccine authorized for use in Singapore GAITHERSBURG, Md., Feb. 15, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that the Singapore Health Sciences Authority (HSA) has issued interim authorization for Nuvaxovid™...

STOCKHOLM, Feb. 15, 2022 /PRNewswire/ -- Mentice, a world leader in simulation solutions for image-guided interventional therapies, today announced the appointment of Jan Grund Pedersen as the Vice President for Strategic Alliances & Business Development.  Jan possesses over twenty-five years of extensive experience within Virtual Reality (VR) simulation and is one of the founding members of Mentice. In 2004,...

BUDAPEST, Hungary, Feb. 14, 2022 /PRNewswire/ -- Chemaxon, a leader in cheminformatics software development for life science research, announced the appointment of Richard Jones as Chief Executive Officer (CEO). Richard follows owner Ferenc (Csizi) Csizmadia in the position. Chemaxon's founder and outgoing CEO, Ferenc Csizmadia, and newly appointed CEO,...

STOCKHOLM, Feb. 14, 2022 /PRNewswire/ -- Elekta (EKTA-B.ST) today published preliminary financial results for the third quarter 2021/22. The demand for Elekta's precision radiation medicine solutions continued to be strong in the quarter, driven by Europe and recovery in several emerging markets such as Egypt and India. Orders grew with 8 percent, the fifth consecutive quarter with underlying order...